New Review Examines Nanomaterial Strategies for Neuroinflammation
Published in Brain/Neurology, Drugs development & discovery, Journals, Nanomedicine.
October 7, 2026
A review published online October 7 in Molecular Medicine Reports examines nanomaterial approaches to neuroinflammation, focusing on immune regulation, oxidative stress and targeted delivery.
Heng Wang, Pei Yang and Wantao Liu discuss strategies intended to shift microglia from inflammatory toward repair-associated states, regulate reactive oxygen species, and use biomimetic carriers to improve blood-brain barrier penetration and targeting of affected tissue.
The review also identifies obstacles to translation: long-term biological safety, understanding how materials are metabolized across organs, and consistent standards for clinical development.
This paper synthesizes existing research rather than reporting a new clinical trial. It outlines experimental therapeutic strategies and unresolved development questions; it does not demonstrate that a nanoparticle treatment safely or effectively treats neuroinflammatory disease in patients.
Source: Wang and colleagues, Molecular Medicine Reports, October 7, 2026.